Logo image of PFE

PFIZER INC (PFE) Stock Fundamental Analysis

NYSE:PFE - New York Stock Exchange, Inc. - US7170811035 - Common Stock - Currency: USD

26.3  +0.4 (+1.54%)

After market: 26.3 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PFE. PFE was compared to 194 industry peers in the Pharmaceuticals industry. PFE scores excellent on profitability, but there are concerns on its financial health. PFE is valued quite cheap, but it does not seem to be growing. PFE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year PFE was profitable.
In the past year PFE had a positive cash flow from operations.
In the past 5 years PFE has always been profitable.
Of the past 5 years PFE 4 years had a positive operating cash flow.
PFE Yearly Net Income VS EBIT VS OCF VS FCFPFE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

PFE has a Return On Assets of 1.94%. This is amongst the best in the industry. PFE outperforms 85.41% of its industry peers.
PFE's Return On Equity of 4.61% is amongst the best of the industry. PFE outperforms 85.95% of its industry peers.
The Return On Invested Capital of PFE (5.71%) is better than 82.16% of its industry peers.
Industry RankSector Rank
ROA 1.94%
ROE 4.61%
ROIC 5.71%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PFE Yearly ROA, ROE, ROICPFE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 7.07%, PFE belongs to the top of the industry, outperforming 85.95% of the companies in the same industry.
In the last couple of years the Profit Margin of PFE has declined.
PFE's Operating Margin of 21.92% is amongst the best of the industry. PFE outperforms 86.49% of its industry peers.
In the last couple of years the Operating Margin of PFE has grown nicely.
PFE's Gross Margin of 70.82% is fine compared to the rest of the industry. PFE outperforms 76.76% of its industry peers.
In the last couple of years the Gross Margin of PFE has declined.
Industry RankSector Rank
OM 21.92%
PM (TTM) 7.07%
GM 70.82%
OM growth 3Y-9.04%
OM growth 5Y2.68%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.02%
GM growth 5Y-1.61%
PFE Yearly Profit, Operating, Gross MarginsPFE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

PFE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for PFE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PFE Yearly Shares OutstandingPFE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B
PFE Yearly Total Debt VS Total AssetsPFE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B 200B

2.2 Solvency

PFE has an Altman-Z score of 1.94. This is not the best score and indicates that PFE is in the grey zone with still only limited risk for bankruptcy at the moment.
PFE has a better Altman-Z score (1.94) than 68.11% of its industry peers.
The Debt to FCF ratio of PFE is 8.23, which is on the high side as it means it would take PFE, 8.23 years of fcf income to pay off all of its debts.
PFE's Debt to FCF ratio of 8.23 is amongst the best of the industry. PFE outperforms 82.70% of its industry peers.
A Debt/Equity ratio of 0.69 indicates that PFE is somewhat dependend on debt financing.
PFE's Debt to Equity ratio of 0.69 is on the low side compared to the rest of the industry. PFE is outperformed by 69.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 8.23
Altman-Z 1.94
ROIC/WACC0.6
WACC9.51%
PFE Yearly LT Debt VS Equity VS FCFPFE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

2.3 Liquidity

PFE has a Current Ratio of 1.00. This is a normal value and indicates that PFE is financially healthy and should not expect problems in meeting its short term obligations.
PFE has a worse Current ratio (1.00) than 85.95% of its industry peers.
A Quick Ratio of 0.73 indicates that PFE may have some problems paying its short term obligations.
PFE's Quick ratio of 0.73 is on the low side compared to the rest of the industry. PFE is outperformed by 88.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.73
PFE Yearly Current Assets VS Current LiabilitesPFE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.95%, which is quite impressive.
PFE shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.06% yearly.
Looking at the last year, PFE shows a small growth in Revenue. The Revenue has grown by 7.42% in the last year.
Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)69.95%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%530%
Revenue 1Y (TTM)7.42%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%24.66%

3.2 Future

PFE is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.50% yearly.
Based on estimates for the next years, PFE will show a decrease in Revenue. The Revenue will decrease by -1.79% on average per year.
EPS Next Y-4.05%
EPS Next 2Y-0.15%
EPS Next 3Y-0.45%
EPS Next 5Y-2.5%
Revenue Next Year-0.06%
Revenue Next 2Y0.15%
Revenue Next 3Y-0.11%
Revenue Next 5Y-1.79%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PFE Yearly Revenue VS EstimatesPFE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
PFE Yearly EPS VS EstimatesPFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.46, the valuation of PFE can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of PFE indicates a rather cheap valuation: PFE is cheaper than 92.97% of the companies listed in the same industry.
PFE is valuated cheaply when we compare the Price/Earnings ratio to 30.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.81 indicates a reasonable valuation of PFE.
Based on the Price/Forward Earnings ratio, PFE is valued cheaper than 90.27% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of PFE to the average of the S&P500 Index (23.06), we can say PFE is valued rather cheaply.
Industry RankSector Rank
PE 8.46
Fwd PE 8.81
PFE Price Earnings VS Forward Price EarningsPFE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

86.49% of the companies in the same industry are more expensive than PFE, based on the Enterprise Value to EBITDA ratio.
PFE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PFE is cheaper than 85.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.12
EV/EBITDA 9.45
PFE Per share dataPFE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

PFE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)7.96
EPS Next 2Y-0.15%
EPS Next 3Y-0.45%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.71%, PFE is a good candidate for dividend investing.
PFE's Dividend Yield is rather good when compared to the industry average which is at 4.34. PFE pays more dividend than 97.84% of the companies in the same industry.
PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 6.71%

5.2 History

The dividend of PFE has a limited annual growth rate of 3.78%.
PFE has been paying a dividend for at least 10 years, so it has a reliable track record.
PFE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.78%
Div Incr Years14
Div Non Decr Years14
PFE Yearly Dividends per sharePFE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

222.18% of the earnings are spent on dividend by PFE. This is not a sustainable payout ratio.
The Dividend Rate of PFE has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP222.18%
EPS Next 2Y-0.15%
EPS Next 3Y-0.45%
PFE Yearly Income VS Free CF VS DividendPFE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE Dividend Payout.PFE Dividend Payout, showing the Payout Ratio.PFE Dividend Payout.PayoutRetained Earnings

PFIZER INC

NYSE:PFE (2/21/2025, 5:22:05 PM)

After market: 26.3 0 (0%)

26.3

+0.4 (+1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)04-29 2025-04-29/bmo
Inst Owners67.53%
Inst Owner Change-0.03%
Ins Owners0.02%
Ins Owner Change-0.22%
Market Cap149.04B
Analysts71.72
Price Target32.12 (22.13%)
Short Float %1.3%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield 6.71%
Yearly Dividend1.64
Dividend Growth(5Y)3.78%
DP222.18%
Div Incr Years14
Div Non Decr Years14
Ex-Date01-24 2025-01-24 (0.43)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.99%
Min EPS beat(2)30.28%
Max EPS beat(2)69.69%
EPS beat(4)4
Avg EPS beat(4)75.1%
Min EPS beat(4)30.28%
Max EPS beat(4)145.39%
EPS beat(8)8
Avg EPS beat(8)49.93%
EPS beat(12)12
Avg EPS beat(12)39.63%
EPS beat(16)15
Avg EPS beat(16)32%
Revenue beat(2)2
Avg Revenue beat(2)9.37%
Min Revenue beat(2)1.51%
Max Revenue beat(2)17.22%
Revenue beat(4)3
Avg Revenue beat(4)5.44%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)17.22%
Revenue beat(8)4
Avg Revenue beat(8)2.89%
Revenue beat(12)7
Avg Revenue beat(12)3.32%
Revenue beat(16)9
Avg Revenue beat(16)3.11%
PT rev (1m)-0.29%
PT rev (3m)-4.87%
EPS NQ rev (1m)-2.23%
EPS NQ rev (3m)-2.08%
EPS NY rev (1m)2.11%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 8.46
Fwd PE 8.81
P/S 2.48
P/FCF 18.12
P/OCF 13.23
P/B 1.61
P/tB N/A
EV/EBITDA 9.45
EPS(TTM)3.11
EY11.83%
EPS(NY)2.98
Fwd EY11.35%
FCF(TTM)1.45
FCFY5.52%
OCF(TTM)1.99
OCFY7.56%
SpS10.61
BVpS16.28
TBVpS-6.4
PEG (NY)N/A
PEG (5Y)7.96
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.61%
ROCE 7.48%
ROIC 5.71%
ROICexc 6.04%
ROICexgc 23.82%
OM 21.92%
PM (TTM) 7.07%
GM 70.82%
FCFM 13.68%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-9.04%
OM growth 5Y2.68%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.02%
GM growth 5Y-1.61%
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 8.23
Debt/EBITDA 3.19
Cap/Depr 44.05%
Cap/Sales 5.05%
Interest Coverage 4.55
Cash Conversion 56.11%
Profit Quality 193.46%
Current Ratio 1
Quick Ratio 0.73
Altman-Z 1.94
F-Score6
WACC9.51%
ROIC/WACC0.6
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.95%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%530%
EPS Next Y-4.05%
EPS Next 2Y-0.15%
EPS Next 3Y-0.45%
EPS Next 5Y-2.5%
Revenue 1Y (TTM)7.42%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%24.66%
Revenue Next Year-0.06%
Revenue Next 2Y0.15%
Revenue Next 3Y-0.11%
Revenue Next 5Y-1.79%
EBIT growth 1Y-9.41%
EBIT growth 3Y-16.17%
EBIT growth 5Y12.02%
EBIT Next Year20.75%
EBIT Next 3Y5.7%
EBIT Next 5Y4.25%
FCF growth 1Y0.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.49%
OCF growth 3YN/A
OCF growth 5YN/A